Skip to main content
. 2021 Jul 1;413(20):5095–5107. doi: 10.1007/s00216-021-03472-8

Table 4.

PLS-DA statistical metrics in the classification of the two ovarian cancer groups (non-chemotherapyOC no chemo, NACTOC with chemo) from benign controls for plasma, serum and urine

Plasma Serum Urine
OC no chemo OC with chemo OC no chemo OC with chemo OC no chemo OC with chemo
Sensitivity 71% 64% 76% 57% 29% 57%
Specificity 84% 88% 98% 96% 87% 92%
Accuracy 81% 85% 94% 91% 76% 88%

OC ovarian cancers, chemo chemotherapy, NACT neo-adjuvant chemotherapy